Authorized and Outstanding Share Capital. As of the date hereof, the authorized share capital of the Company consists of (A) 500,000,000 Common Shares, of which, 3,209,495 are issued and outstanding and 1,250,000 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes) exercisable or exchangeable for, or convertible into, Common Shares (B) 100,000,000 Preferred Shares, none of which are issued and outstanding, and (C) 100,000,000 Class B Shares, none of which are outstanding. No Common Shares are held in the treasury of the Company.
Authorized and Outstanding Share Capital. The authorized share capital of the Issuer is US$50,000,000. At the date of this Agreement, the Issuer has a total of 14,146,497 Shares issued and outstanding. All such issued and outstanding Shares have been duly authorized and validly issued and are fully-paid and non-assessable. After giving effect to the issue and sale of the Subscription Shares (and assuming the exercise of all warrants issued and outstanding), a total of 17,146,497 Shares will be issued and outstanding.
Authorized and Outstanding Share Capital. As of the date hereof, the authorized share capital of the Company consists of (i) 300,000,000 Ordinary Shares, of which, 179,180,431 Ordinary Shares are issued and outstanding and 0 Ordinary Shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes) exercisable or exchangeable for, or convertible into, Ordinary Shares, and (ii) 200,000,000 Class B ordinary shares, $0.0001 par value per share, of which, 3,786,960 shares are issued and outstanding. “Convertible Securities” means any share capital or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share capital or other security of the Company (including, without limitation, Ordinary Shares) or any of its Subsidiaries.
Authorized and Outstanding Share Capital. The Corporation is authorized to issue an unlimited number of Common Shares including shares duly authorized and reserved for issuance pursuant to Section 5(1)(f) below, of which 45,654,684 Common Shares are issued and outstanding as of June 5, 2019. All of the issued and outstanding shares of the Corporation are fully paid and non-assessable and have been duly and validly authorized and issued free and clear of any security interest, mortgage, pledge, lien, encumbrance or claim.
Authorized and Outstanding Share Capital. As of the date hereof, an unlimited amount of Common Shares are authorized, of which 3,774,262 Common Shares are issued and outstanding and no shares are reserved for issuance pursuant to Common Share Equivalents (as defined below) (other than the Notes) exercisable or exchangeable for, or convertible into, Common Shares. No Common Shares are held in the treasury of the Company. “Common Share Equivalents” means any share capital or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share capital or other security of the Company (including, without limitation, Common Shares) or any of its Subsidiaries.
Authorized and Outstanding Share Capital. As of the date hereof, the authorized share capital of the Company consists of (A) an unlimited number of Common Shares, of which, 107,353,400 are issued and outstanding and 15,544,772 shares may be issued pursuant to Convertible Securities (other than the Note, the Warrants, the New Investor Securities and the Placement Agent Securities) exercisable or exchangeable for, or convertible into, Common Shares and (B) an unlimited number of Preferred Shares, none of which are issued and outstanding. No Common Shares are held in the treasury of the Company.
Authorized and Outstanding Share Capital. As of the date hereof, the authorized share capital of the Company consists of 200,000,000 ordinary shares, par value GBP 0.30 per share, which may be designated as Ordinary Shares or B Ordinary Shares, of which, 94,885,614 Ordinary Shares and 15,256,925 B Ordinary Shares are issued and outstanding. As of the date hereof, there are 27,412,381 Ordinary Shares reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes) exercisable or exchangeable for, or convertible into, Ordinary Shares. No Ordinary Shares are held in the treasury of the Company.
Authorized and Outstanding Share Capital. The authorized share capital of the Issuer is US$25,000,000 and subject to the approval and adoption of the proposed Amended and Restated Memorandum and Articles of Association by the shareholders of the Issuer at its Shareholders’ Meeting, shall be increased to US$50,000,000. At the date of this Agreement, the Issuer has a total of 11,309,497 Shares issued and outstanding. All such issued and outstanding Shares have been duly authorized and validly issued and are fully-paid and non-assessable. After giving effect to the issue and sale of the Subscription Securities (and assuming the exercise of all Warrants), a total of 16,809,497 Shares will be issued and outstanding.
Authorized and Outstanding Share Capital. As of March 1, 2018, the authorized share capital of the Company consists of (A) unlimited Common Shares, of which, 7,556,328 are issued and outstanding as of March 1, 2018 and 2,435,019 of which are reserved for issuance pursuant to the Companyªs outstanding Convertible Securities (as defined below) (not including the Common Shares issuable upon exercise of the Existing Warrant or the Exchange Shares), in each case exercisable or exchangeable for, or convertible into, Common Shares, and (B) no Preferred Shares. No Common Shares are held in the treasury of the Company. “Convertible Securities” means any share capital or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share capital or other security of the Company (including, without limitation, Common Shares) or any of its Subsidiaries.
Authorized and Outstanding Share Capital. As of the date hereof (and not as of the Closing), the authorized share capital of the Company consists of (A) 604,758 Ordinary Shares, of which, 119,977 are issued and outstanding and 52,789 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, Ordinary Shares (B) 74,220 Ordinary A Shares, of which, 65,814 are issued and outstanding (C) 242,000 Preferred A Shares, 201,712 of which are issued and outstanding (D) 14,000 Preferred A1 Shares, 13,423 of which are issued and outstanding and (E) 65,000 Preferred A2 Shares, 64,588 of which are issued and outstanding. No Ordinary Shares are held in the treasury of the Company. The outstanding securities of the Company, on a fully-diluted basis, are owned by and registered in the names of such security holders, and in such numbers as specified in the capitalization table attached hereto as Schedule 3(r)(ii). “Convertible Securities” means any share capital or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share capital or other security of the Company (including, without limitation, Ordinary Shares) or any of its Subsidiaries. Immediately prior to the Closing, the Company shall complete the Capital Restructuring (as defined in the Merger Agreement) pursuant to the Merger Agreement, with the result at all classes of capital stock other than Ordinary Shares shall become and be converted into Ordinary Shares, as provided in the Merger Agreement.
